Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schepke

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 4, 2009
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding]M Schepke
Deutsche Medizinische Wochenschrift (1946)|June 7, 2006
[Primary prevention of variceal bleeding in cirrhosis]M Schepke
Deutsche Medizinische Wochenschrift (1946)|September 7, 2001
[Liver cirrhosis--case report]M Schepke, T Sauerbruch
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Variceal hemorrhage: primary and secondary prophylaxis]T Sauerbruch, M Schepke
World Journal of Gastroenterology|January 31, 2002
Transjugular portosystemic stent shunt in treatment of liver diseasesM Schepke, T Sauerbruch
Endoscopy|May 1, 1997
Sclerotherapy is out--nearlyT Sauerbruch, M Schepke
Zeitschrift Fur Gastroenterologie|September 10, 2016
Causes of altered liver function tests - the role of alpha-1 antitrypsinJ Stollenwerk, M Schepke, E Biecker
Zeitschrift Fur Gastroenterologie|February 1, 1997
[Endoscopy in patients at risk for bleeding]M Schepke, C Unkrig, T Sauerbruch
Endoscopy|August 10, 2002
Long-term results and prognostic factors in the treatment of achalasia with botulinum toxinM Neubrand, C Scheurlen, M Schepke, et al.
Acta Endocrinologica|January 1, 1993
Hormonal responses to the new potent GnRH antagonist CetrorelixD Klingmüller, M Schepke, C Enzweiler, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|September 4, 2009
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding]M Schepke
Deutsche Medizinische Wochenschrift (1946)|June 7, 2006
[Primary prevention of variceal bleeding in cirrhosis]M Schepke
Deutsche Medizinische Wochenschrift (1946)|September 7, 2001
[Liver cirrhosis--case report]M Schepke, T Sauerbruch
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Variceal hemorrhage: primary and secondary prophylaxis]T Sauerbruch, M Schepke
World Journal of Gastroenterology|January 31, 2002
Transjugular portosystemic stent shunt in treatment of liver diseasesM Schepke, T Sauerbruch
Endoscopy|May 1, 1997
Sclerotherapy is out--nearlyT Sauerbruch, M Schepke
Zeitschrift Fur Gastroenterologie|September 10, 2016
Causes of altered liver function tests - the role of alpha-1 antitrypsinJ Stollenwerk, M Schepke, E Biecker
Zeitschrift Fur Gastroenterologie|February 1, 1997
[Endoscopy in patients at risk for bleeding]M Schepke, C Unkrig, T Sauerbruch
Endoscopy|August 10, 2002
Long-term results and prognostic factors in the treatment of achalasia with botulinum toxinM Neubrand, C Scheurlen, M Schepke, et al.
Acta Endocrinologica|January 1, 1993
Hormonal responses to the new potent GnRH antagonist CetrorelixD Klingmüller, M Schepke, C Enzweiler, et al.
Pageof 4